目的：探讨分析采用联合异丙托溴铵雾化吸入治疗儿童重症支气管哮喘的临床效果。方法：选取我院2012年1月至2013年12月收治的120例小儿重症支气管哮喘患者为研究对象，将其随机平均分成两组，各60例。对照组患儿给予常规治疗，观察组患儿在对照组基础上联合异丙托溴铵雾化吸入治疗，观察两组临床治疗效果。结果：观察组患者总有效率为91.7%，显著高于对照组71.7%，差异具有统计学意义（P<0.05）。结论：采用联合异丙托溴铵雾化吸入治疗儿童重症支气管哮喘的临床效果较显著，能有效提高患儿生活质量，值得临床应用推广。%Objective: To investigate the analysis using the combinedipratropium bromide aerosol inhalation of clinical effect of the treatment of children with severe bronchial asthma. Methods:120cases of children with severe bronchial asthma patients in our hospital in 2012 January -2013 year in December as the research object, randomly divided into two groups, 60 cases in each. The control group were given conventional treatment, the observation group patients in the control group based on joint ipratropium bromide inhalation therapy, to observe the clinical therapeutic effect of the two groups. Results: The patients in the observation group the total effective rate was 91.7%, significantly higher than the controlgroup 71.7%, the difference was statistically significant (p<0.05). Conclusion:The combined ipratropium bromide aerosol inhalation ofclinical effect of the treatment of children with severe bronchial asthma is significant, and can effectively improve the quality of life ofpatients, is worthy of clinical application.
展开▼
